Related Experiment Videos
CM101, a polysaccharide antitumor agent, does not inhibit wound healing in murine models
T E Quinn1, G B Thurman, A K Sundell
1Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, USA.
Journal of Cancer Research and Clinical Oncology
|January 1, 1995
Abstract:
CM101 (previously called GBS toxin), a new anticancer polysaccharide that induces inflammatory reactions in neovasculature of tumors, does not cause similar reactions in neovasculature of healing wounds. It appears that treatment with CM101 will not interfere with normal wound healing in cancer patients.